Physician profile
George D Johnston
NPI 1891757464
$13,884.45
in general payments reported to CMS, 2019-2025
29 companies · $578 in 2025
The $578 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,931 · 2020: $1,359 · 2021: $7,002 · 2022: $728 · 2023: $366 · 2024: $919 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,863.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,442.36 | 2019-2025 | Bionic Navigator, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Vertiflex, INC. | $2,222.70 | 2019 | |
| Abbott Laboratories | $839.06 | 2019-2025 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $818.62 | 2020-2023 | Intracept |
| Mml US, INC. | $253.95 | 2023-2025 | Reactiv8 |
| Daiichi Sankyo INC. | $252.41 | 2019 | |
| Saluda Medical Americas, INC. | $184.69 | 2024-2025 | Evoke |
| Medtronic, INC. | $135.90 | 2022-2024 | Intellis Adaptivestim, Synchromedii |
| Vertos Medical, INC. | $120.86 | 2019-2023 | Mild Device Kit |
| Pfizer INC. | $77.65 | 2019-2025 | |
| Medtronic USA, INC. | $58.57 | 2019-2020 | |
| Abbvie INC. | $55.00 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $48.37 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $37.10 | 2021 | |
| Grt US Holding, INC. | $34.31 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $33.70 | 2019-2020 | |
| Curonix LLC | $31.58 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $30.73 | 2022 | |
| Averitas Pharma INC. | $28.99 | 2024 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $26.11 | 2023 | Exparel, Iovera |
| Stimwave Technologies Incorporated | $25.10 | 2021 | |
| Pacira Therapeutics, INC. | $21.21 | 2020 | |
| Biotronik Nro, INC. | $18.28 | 2025 | Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $16.54 | 2022 | |
| Allergan, INC. | $16.37 | 2019 | |
| Painteq LLC | $14.48 | 2021 | |
| Mdd US Operations, LLC | $14.44 | 2019 | |
| Avanos Medical | $12.80 | 2021 | |
| Amgen INC. | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.